| Literature DB >> 35708968 |
Gabriela Blanchard1, Christine Pich1, Daniel Hohl1,2.
Abstract
Primary cilium (PC) is a microtubule-based organelle found on the apical surface of most mammalian cell types, playing a role in development and tissue homeostasis. Ciliopathies are a rapidly growing group of human diseases characterized by disordered cilium. PC plays an important role in pathogenesis of basal cell cancer, the most common human malignancy. A significant increase in ciliation has been observed in the epidermis of atopic dermatitis and psoriasis patients. Spontaneously immortalized human keratinocytes, HaCaT are a model to study the epidermal homeostasis and pathophysiology. In contrast to what has been previously described, here, we show that HaCaT can be efficiently ciliated. In HaCaT cells, differentiation significantly increased the number of ciliated cells and we were able to analyse in detail the ciliary length progression with duration of differentiation. As the number of recognized ciliopathies continues to increase, the importance of ciliary models also rises. Even though keratinocytes do not become as highly and rapidly ciliated as cell lines frequently used in ciliary studies, they are a better model for the study of skin ciliopathies. Detailed progression of ciliation in HaCaT could serve as the basis for ciliary studies in this cell line.Entities:
Keywords: cancer; differentiation; keratinocyte biology; keratinocytes; primary cilium
Mesh:
Year: 2022 PMID: 35708968 PMCID: PMC9542831 DOI: 10.1111/exd.14626
Source DB: PubMed Journal: Exp Dermatol ISSN: 0906-6705 Impact factor: 4.511
FIGURE 1Differentiation of HaCaT keratinocytes increases their ciliation. (A) Western blot showing a representative image of K10 protein expression during differentiation of HaCaT. α‐tubulin used as a loading control. (B) Representative immunofluorescence images of acetylated tubulin (green) and rootletin (red) co‐staining in non‐differentiated and 7 days‐differentiated HaCaT. Scale bar, 10 μm. (C) Quantification of ciliated HaCaT upon non‐differentiated and 7 days differentiated conditions. Unpaired t test with Welch's correction (N = 10, 16). (D) Cilium length measured in HaCaT at D3, D5 and D7 of differentiation. Ordinary one‐way ANOVA test with Holm‐Šidák's correction (N = 64, 68, 59). (E) Representative images of SMO IN/OUT assay in 7 days‐differentiated HaCaT. Scale bar, 5 μm. Ac‐tubul, acectylated tubulin; IB, immunoblot; ND, non‐differentiated, D3, D5, D7: day 3, 5 and 7 of differentiation, respectively
List of primary and secondary antibodies used
| Target | Type | Host | Concentration | Supplier | Accession number |
|---|---|---|---|---|---|
| Acetylated α‐tubulin (clone 6‐11B‐1) | Primary, monoclonal | Mouse | IF: 1/1000 | Sigma‐Aldrich | 6793 |
| Keratin 10 (clone DE‐K10) | Primary, monoclonal | Mouse | WB: 1/500 | NeoMarkers, Thermo Scientific | MS‐611‐P0 |
| Rootletin (CROCC) | Primary, polyclonal | Rabbit | IF: 1/200 | NovusBio | NBP1‐80820 |
| GFP (clone 3E6) | Primary, monoclonal | Mouse | IF: 1/250 | Invitrogen | A‐11120 |
| α‐tubulin (clone DM1A) | Primary, monoclonal | Mouse | WB: 1/5000 | Sigma‐Aldrich | T9026 |
| ECL™ Anti‐mouse IgG, HRP‐conjugated | Secondary, polyclonal | Sheep | WB: 1/5000 | GE Healthcare UK Limited | NA931V |
| AlexaFluor‐488 conjugated anti‐mouse | Secondary, polyclonal | Chicken | IF: 1/500 | Invitrogen | A21200 |
| AlexaFluor‐488 conjugated anti‐rabbit | Secondary, polyclonal | Donkey | IF: 1/500 | Invitrogen | A10040 |
| AlexaFluor‐546 conjugated anti‐mouse secondary | Secondary, polyclonal | Goat | IF: 1/500 | Invitrogen | A11003 |
Abbreviations: IF, immunofluorescence; WB, Western blot.